Occudo Quantitative Strategies LP Natera, Inc. Transaction History

Occudo Quantitative Strategies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$59.21 - $92.9 $158,327 - $248,414	2,674 New	2,674 $244,000
Q3 2022 Nov 14, 2022	SELL	$36.93 - $56.68 $209,577 - $321,659	-5,675 Reduced 35.08%	10,503 $460,000
Q2 2022 Aug 15, 2022	SELL	$28.13 - $44.54 $1.16 Million - $1.84 Million	-41,262 Reduced 71.83%	16,178 $573,000
Q1 2022 May 16, 2022	BUY	$30.32 - $91.33 $1.74 Million - $5.25 Million	57,440 New	57,440 $2.34 Million
Q1 2021 May 14, 2021	SELL	$91.47 - $124.36 $913,327 - $1.24 Million	-9,985 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$66.66 - $111.74 $665,600 - $1.12 Million	9,985 New	9,985 $994,000

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.